About

Fred Dom is one of the original founders and Chief Executive Officer of HiFiBiO Therapeutics. He is a serial entrepreneur with expertise in private capital investment and biotech formation in the Netherlands, France, and US. Fred holds board positions in Calyxia (France), Kapsera (France) and Oncode Accelerator (Dutch public-private initiative with €325 million funding from National Growth Fund), and he is a member of the Advisory Board of Dutch Life Science and Health industry.

Previously, Fred was Chief Executive Officer and co-founder of Saber Bio (created in 2021), which was acquired by a world leading life science tools company in 2024. Before Saber, Fred held CEO and CFO positions at HiFiBiO Therapeutics.

Fred holds a B.Sc. and M.Sc. in economics from the Erasmus University in Rotterdam, the Netherlands.